NAV
$100.23
AUM
$1.2B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.92
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +8.45% | +2.58% | +6.48% | +18.92% | +17.21% | +9.70% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.41% |
| 2 | HSBA.L | HSBC Holdings PLC | 1.27% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.17% |
| 4 | AZN.L | AstraZeneca PLC | 1.09% |
| 5 | NOVN.SW | Novartis AG Registered Shares | 1.07% |
| 6 | RY | Royal Bank of Canada | 1.05% |
| 7 | NESN.SW | Nestle SA | 1.03% |
| 8 | SHEL.L | Shell PLC | 0.93% |
| 9 | SIE.DE | Siemens AG | 0.89% |
| 10 | BHP.AX | BHP Group Ltd | 0.87% |
The fund invests all of its assets in equity securities comprising the Solactive GBS Developed Markets ex United States Large & Mid Cap USD Index NTR, depositary receipts based on securities comprising the index, ETFs providing exposure to such securities, and derivatives with economic characteristics similar to such securities or the index. The index is a free float market capitalization weighted index designed to measure the performance of developed market large- and mid-capitalization companies. It is non-diversified.
Inception Date: 2020-04-22